CancerDrs Find care

Ovarian Cancer clinical trials in Mississippi

9 actively recruiting ovarian cancer trials at 8 sites across Mississippi.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Academic/Other

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among prem…

Sponsor: NRG Oncology
NCT ID: NCT05879926
Sites in Mississippi:
  • Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
  • Baptist Cancer Center-Grenada — Grenada, Mississippi
  • Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
  • Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
  • Baptist Memorial Hospital and Cancer Center-Desoto — Southhaven, Mississippi
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it dev…

Sponsor: Children's Oncology Group
NCT ID: NCT03067181
Sites in Mississippi:
  • University of Mississippi Medical Center — Jackson, Mississippi
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part o…

Sponsor: Children's Oncology Group
NCT ID: NCT06513962
Sites in Mississippi:
  • University of Mississippi Medical Center — Jackson, Mississippi
View on ClinicalTrials.gov →
Phase 3 Recruiting Industry

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer without the cancer get…

Sponsor: Merck Sharp & Dohme LLC
NCT ID: NCT06824467
Sites in Mississippi:
  • St. Dominic's Hospital ( Site 0064) — Jackson, Mississippi
View on ClinicalTrials.gov →
Phase 2 Recruiting NIH

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally adva…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05564377
Sites in Mississippi:
  • Baptist Memorial Hospital and Cancer Center-Golden Triangle — Columbus, Mississippi
  • Baptist Cancer Center-Grenada — Grenada, Mississippi
  • Gulfport Memorial Hospital — Gulfport, Mississippi
  • Baptist Memorial Hospital and Cancer Center-Union County — New Albany, Mississippi
  • Baptist Memorial Hospital and Cancer Center-Oxford — Oxford, Mississippi
View on ClinicalTrials.gov →
Phase 2 Recruiting Academic/Other

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EOC. Patients with biopsy confirmed, newly diagnosed, advanced-stage serous EOC deemed appro…

Sponsor: University of Alabama at Birmingham
NCT ID: NCT04606914
Sites in Mississippi:
  • University of Mississippi Medical Center — Oxford, Mississippi
View on ClinicalTrials.gov →
Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.
NCT ID: NCT03452774
Sites in Mississippi:
  • Massive Bio SYNERGY-AI site — Hattiesburg, Mississippi
View on ClinicalTrials.gov →
Recruiting Academic/Other

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

The overarching objective of this project is to develop a pan-gynecologic cancer detection test using gynecologic (unique endometrial, cervical, and ovarian cancer) cancer-specific methylated DNA markers and high-risk human papilloma virus…

Sponsor: Mayo Clinic
NCT ID: NCT05051722
Sites in Mississippi:
  • University of Mississippi Medical Center — Jackson, Mississippi
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20